Breastcancer: Clinical Trials

22 trials for Breastcancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 3 unknown, 2 terminated, 1 active not recruiting. 12 Not applicable, 5 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 8, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 15Completed 4, Terminated 1
Phase 21Completed 1
Phase 31Unknown 1
Phase 41Completed 1

Follow Breastcancer: new trials by email Literature Review of Breastcancer trials Research Report on Breastcancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast Surgery
Analgesia mangement group A,B - Breastcancer, Perioperative Pain
Not applicableUnknownAin Shams University802024-07-252024-07-23
A PK Study of Oraxol in Breast Cancer Patients
Oraxol - Breastcancer
Phase 1CompletedAthenex, Inc.242019-04-222021-08-06
Establishing Technique for PECS2 Catheter Insertion
Pectoralis II block & catheter without Lidocaine dissection, Pectoralis II block & catheter with Lidocaine dissection, catheter insertion - Breastcancer, Phyllodes Breast Tumor
Not applicableCompletedKasr El Aini Hospital802018-11-012020-09-09
Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance
BLES system and conventional lumpectomy - Breastcancer
Not applicableTerminatedRadboud University Medical Center222018-02-192020-05-29
An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007
Oraxol - Breastcancer
Phase 1TerminatedAthenex, Inc.112017-10-252022-03-03
Breast, Omega 3 Free Fatty Acid, Ph 0
Omega-3 FFA - Breastcancer
Not applicableCompletedThe University of Texas Health Science Center at San Antonio212017-06-122021-03-17
A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients
Oraxol - Breastcancer
Phase 1CompletedHealth Hope Pharma282017-05-092025-03-12
SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
SV-BR-1-GM, Cyclophosphamide, Interferon-alpha-2b - Breastcancer, Breast Neoplasm
Phase 1 / Phase 2CompletedBriaCell Therapeutics Corporation242017-05-052021-01-29
Study Evaluating the Efficacy of Loco-regional Anaesthesia PECS on Chronic Pain of a Mastectomy
Loco-regional anaesthesia - Breastcancer, Mastectomy
Not applicableCompletedCentre Oscar Lambret1942017-04-032026-09-17
Empowering Latinas to Obtain Breast Cancer Screenings
Empowerment, Education - Breastcancer, Breast Diseases
Not applicableCompletedUniversity of Illinois at Chicago1452017-03-012021-11-18
Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years
WBI 5 fractions, WBI 15 fractions, LNI 5 fractions - Breastcancer
Not applicableActive not recruitingUniversity Hospital, Ghent1442017-02-152023-12-22
Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
Information - Breastcancer
UnknownGustave Roussy, Cancer Campus, Grand Paris6002016-12-012016-12-20
Identification of C7; Evaluations of 2 Sonographic Methods Using a Transverse and a Sagittal Scan.
Ultrasound sagittal scan, Ultrasound transverse scan, Fluoroscopic technique - Breastcancer
Not applicableCompletedMahidol University202016-12-012017-01-18
Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast Cancer
video game program - Lymphedema, Breastcancer
Not applicableCompletedUniversidad de Burgos112016-11-012017-05-04
Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer
adhesive barrier - Breastcancer, Surgery: Axillary Dissection
Phase 3UnknownSamsung Medical Center1702016-11-012017-01-05
The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy
PEG-rhG-CSF - Breastcancer
Phase 4CompletedPeking University2402016-09-082019-01-18
Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer
Post Mastectomy Radiation therapy - Breastcancer
Not applicableRecruitingTata Memorial Centre10222016-05-272025-04-10
Presential Vs Online Group-based Psychosocial Treatment for Breast Cancer Survivors.
Positive Psychotherapy, Positive Online Psychotherapy, Cognitive Behavioral Therapy - Breastcancer, Emotional Disorder
Not applicableCompletedInstitut Català d'Oncologia3652016-01-012020-02-18
CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer
Lymph Node, Breastcancer
CompletedZhejiang Cancer Hospital3592015-04-012019-10-04
The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy
Breastcancer, Invasive Breast Carcinoma by Gene Expression Profile
CompletedDiakonessenhuis, Utrecht6602013-01-012017-02-15

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (6)  ·  Breast Diseases (1)  ·  Inflammation (1)  ·  Lymphatic Metastasis (1)  ·  Lymphedema (1)  ·  Patient Satisfaction (1)  ·  Phyllodes Tumor (1)

Broader conditions

Neoplasms (7)  ·  Skin Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Breast Diseases (6)  ·  Neoplasms by Site (6)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Behavior (1)  ·  Health Behavior (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Lymphatic Diseases (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplastic Processes (1)

Interventions

Catheterization (1)  ·  Catheters (1)  ·  Cognitive Behavioral Therapy (1)  ·  Cyclophosphamide (1)  ·  Educational Status (1)  ·  Introns (1)  ·  Omacor (1)  ·  Paclitaxel (1)  ·  Trastuzumab (1)  ·  pegylated granulocyte colony-stimulating factor (1)

Sponsors

Ain Shams University (2)  ·  Athenex, Inc. (2)  ·  BriaCell Therapeutics Corporation (1)  ·  Cancer Insight, LLC (1)  ·  Centre Oscar Lambret (1)  ·  Diakonessenhuis, Utrecht (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  Health Hope Pharma (1)  ·  Institut Català d'Oncologia (1)  ·  Kasr El Aini Hospital (1)  ·  Mahidol University (1)  ·  Peking University (1)  ·  Radboud University Medical Center (1)  ·  Samsung Medical Center (1)  ·  Tata Memorial Centre (1)

Countries

China (3)  ·  United States (3)  ·  France (2)  ·  Netherlands (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Belgium (1)  ·  Egypt (1)  ·  India (1)  ·  South Korea (1)

Top investigators

Cristian Ochoa, PhD (1)  ·  David Cutler, MD (1)  ·  Erwei Song, Pro.f (1)  ·  George E Peoples, MD (1)  ·  George E Peoples, MD, FACS (1)  ·  Herui Yao, Pro.f (1)  ·  Liv Veldeman, M.D., PhD (1)  ·  Mohamed Ah Mansour, ass.prof (1)  ·  Ritse Mann, MD, PhD (1)  ·  Tabassum Wadasadawala, MBBS,MD,DNB (1)  ·  Tao Ouyang, MD (1)  ·  Thijs van Dalen, Dr (1)  ·  Tsu-Yi Chao, MD, DMS, PhD (1)

Results publications

PMID 31659631, PMID 32618395, PMID 34352935, PMID 37280082, PMID 37492633

NIH funding

K01CA193918 (1)